Skip to main content
logo
Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
73.70
+1.75 (2.43%)
Aug 8, 2025, 1:45 PM - Market open

NV5 Global Revenue

Solventum had revenue of $2.16B in the quarter ending June 30, 2025, with 3.84% growth. This brings the company's revenue in the last twelve months to $8.39B, up 2.21% year-over-year. In the year 2024, Solventum had annual revenue of $8.25B with 0.70% growth.

Revenue (ttm)
$8.39B
Revenue Growth
+2.21%
P/S Ratio
1.49
Revenue / Employee
$381,273
Employees
22,000
Market Cap
12.78B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.25B57.00M0.70%
Dec 31, 20238.20B67.00M0.82%
Dec 31, 20228.13B-41.00M-0.50%
Dec 31, 20218.17B890.00M12.22%
Dec 31, 20207.28B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

SOLV News

More News